Table 2.

Effect of treatment on immediate early genes expression in social decision-making network (SDMN) areas.

	Main effects		MM vs. MD			MM vs. MS			MD vs. MS
Areas	F	p	t	p	d	t	p	d	t	p	d
c-fos
VVm	0.816	0.462	0.550	0.583	0.031	0.820	0.583	0.050	1.268	0.583	0.086
Vs	0.821	0.458	1.004	0.473	0.072	1.170	0.473	0.061	0.160	0.873	0.008
TA	3.839	0.042	1.250	0.211	0.081	2.770	0.017	0.140	1.421	0.211	0.069
GC	0.426	0.663	0.910	0.363	0.091	0.319	0.750	0.017	0.591	0.555	0.036
PPa	0.970	0.400	1.027	0.457	0.047	1.277	0.457	0.119	0.286	0.775	0.016
egr-1
VVm	1.528	0.247	0.675	0.500	0.038	1.119	0.395	0.070	1.729	0.252	0.087
Vs	0.156	0.857	0.166	0.868	0.010	0.552	0.868	0.030	0.362	0.868	0.018
TA	1.176	0.333	0.808	0.419	0.040	0.831	0.419	0.057	0.1.533	0.376	0.074
GC	0.918	0.419	1.094	0.411	0.066	1.174	0.411	0.059	0.130	0.897	0.008
PPa	1.705	0.213	0.078	0.938	0.004	1.600	0.164	0.109	1.618	0.164	0.081

Main effects and post hoc comparisons between treatments. d: effect size estimate (Cohen’s d); Treatments: MM, Mirror-Mirror; MD, Mirror-Dominant; MS, Mirror-Subordinate; GC, central gray; PPa, anterior part of the periventricular preoptic nucleus; TA, nucleus anterior tuberis; VVm, medial part of the ventral subdivision of the ventral telencephalon; Vs, supracommissural nucleus of the ventral telencephalon; c-fos degrees of freedom for F-test: GC: (2, 12); PPa: (2, 16); TA: (2, 17); VVm: (2, 14); Vs: (2, 16); egr-1 degrees of freedom for F-test: GC: (2, 16); PPa: (2, 16); TA: (2, 17); VVm: (2, 16); Vs: (2, 17); statistically significant values are in bold.